Healthcare Industry News: Inverness Medical Innovations
News Release - June 10, 2010
Bosch and Inverness Settle LitigationFARMINGTON HILLS, MI and WALTHAM, MA--(HSMN NewsFeed) - Robert Bosch North America Corporation and Inverness Medical Innovations today announced that they have reached an agreement that settles Health Hero Network, Inc. v. Alere Medical, Inc., Civil Action No. 07-CV-5031, and Healthways, Inc. and Robert Bosch North America Corp. v. Alere LLC, Civil Action No. 08-CV-06337, both of which were pending in the United States District Court for the Northern District of Illinois. While the financial terms of the agreement have not been disclosed, the agreement includes an exchange of cross-licenses of certain patent rights.
The Bosch Group is a leading global supplier of technology and services. In the areas of automotive and industrial technology, consumer goods, and building technology, some 275,000 associates generated sales of $53 billion (38.2 billion euros) in fiscal 2009. The Bosch Group comprises Robert Bosch GmbH and its more than 300 subsidiaries and regional companies in over 60 countries. If its sales and service partners are included, then Bosch is represented in roughly 150 countries. This worldwide development, manufacturing, and sales network is the foundation for growth. Each year, Bosch spends more than $5 billion (3.5 billion euros) for research and development, and applies for some 3,800 patents worldwide. With all its products and services, Bosch enhances the quality of life by providing solutions which are both innovative and beneficial.
In the U.S., Canada and Mexico, the Bosch Group manufactures and markets automotive original equipment and aftermarket products, industrial drives and control technology, power tools, security and communication systems, packaging technology, thermotechnology, household appliances, solar energy and healthcare products. Having established a regional presence in 1906, Bosch employs over 20,000 associates in more than 70 locations, with reported sales of $7.3 billion in fiscal 2009.
For more information, visit www.bosch.us.
About Inverness Medical Innovations
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. For more information on Inverness Medical Innovations visit www.invernessmedical.com.
Source: Robert Bosch Healthcare
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.